It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2006.
2006 | Mumbai, Maharashtra, India | ActiveTyfill Pharmapack Limited, a active public limited company, was established on 15 February 2006 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2006PLC160043. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a active non-compliant status. Its leadership includes Harsha Dushyant Mulani (Director), Harsh Kirit Shandilya (Director), Champa Kapadia Narottam (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 41 Worli Seaface, Shandilya Villa,, Mumbai, Maharashtra, 400025.
U24230MH2006PLC160043
160043
15 February 2006
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Tyfill Pharmapack Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsha Dushyant Mulani | Director | 15 Feb 2006 | Current |
| Harsh Kirit Shandilya | Director | 15 Feb 2006 | Current |
| Champa Kapadia Narottam | Director | 15 Feb 2006 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Tyfill Pharmapack Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 52.01% increase in profit. The company's net worth dipped by a decrease of 3.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Tyfill Pharmapack had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Tyfill Pharmapack, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tyfill Pharmapack, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tyfill Pharmapack's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Tyfill Pharmapack Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Tyfill Pharmapack Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Harsha Dushyant Mulani was appointed as a Director was appointed as a Director on 15 Feb 2006 & has been associated with this company since 19 years 9 months . was recorded as a recent event.
Harsh Kirit Shandilya was appointed as a Director was appointed as a Director on 15 Feb 2006 & has been associated with this company since 19 years 9 months . was recorded as a recent event.
The activity Champa Kapadia Narottam was appointed as a Director was appointed as a Director on 15 Feb 2006 & has been associated with this company since 19 years 9 months . was completed.
Progress on Tyfill Pharmapack Limited was registered on 15 Feb 2006 with Roc Mumbai & aged 19 years 9 months as per MCA records. was documented.
The CIN of Tyfill Pharmapack Limited is U24230MH2006PLC160043.
Tyfill Pharmapack Limited is headquartered at 41 Worli Seaface, Shandilya Villa,, Mumbai, Maharashtra, 400025.
Tyfill Pharmapack Limited was incorporated on 15 February 2006.
The current directors of Tyfill Pharmapack Limited are
The primary industry of Tyfill Pharmapack Limited is Manufacturing.
Tyfill Pharmapack Limited is unlisted.
The authorized capital of Tyfill Pharmapack Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Tyfill Pharmapack Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX